P2RX1 and epilepsy: The newly gained knowledge paved the way for future clinical applications of ATP receptor antagonists that may include neuropathic pain, hyperalgesia, neuroinflammation, injury, ischemia, neurodegenerative disorders, epilepsy, among other pathologies [19].